Literature DB >> 20651828

Pandemic influenza A (H1N1) virus infection and avian influenza A (H5N1) virus infection: a comparative analysis.

Christine Korteweg1, Jiang Gu.   

Abstract

The 2009 H1N1 and H5N1 influenza viruses are newly (re-) emerged influenza A viruses (2009 A(H1N1) and A(H5N1), respectively) that have recently posed tremendous health threats in many regions worldwide. With the 2009 outbreak of H1N1 influenza A, the world witnessed the first influenza pandemic of the 21st century. The disease has rapidly spread across the entire globe, and has resulted in hundreds of thousands of cases with confirmed infection. Although characterized by high transmissibility, the virulence and fatality of the 2009 A(H1N1) influenza virus have thus far remained relatively low. The reverse holds true for A(H5N1) influenza; at a fatality rate that exceeds 60%, it is known to cause severe damage to the human respiratory system, but is not presently capable of efficient transmission from human to human. Apart from the clear differences between the two types of influenza, there are some significant similarities that warrant attention. In particular, the more severe and fatal 2009 A(H1N1) influenza cases have shown symptoms similar to those reported in cases of A(H5N1) influenza. Histopathological findings for these cases, to the extent available, also appear to have similarities for both diseases in terms of damage and severity. Here we review important recent publications in this area, and we discuss some of the key commonalities and contrasts between the two influenza A types in terms of their biology, origins, clinical features, pathology and pathogenesis, and receptors and transmissibility.

Entities:  

Mesh:

Year:  2010        PMID: 20651828     DOI: 10.1139/O10-017

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  7 in total

1.  Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus.

Authors:  Kevin B Walsh; John R Teijaro; Peter R Wilker; Anna Jatzek; Daniel M Fremgen; Subash C Das; Tokiko Watanabe; Masato Hatta; Kyoko Shinya; Marulasiddappa Suresh; Yoshihiro Kawaoka; Hugh Rosen; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-29       Impact factor: 11.205

2.  Characterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B Viruses.

Authors:  Louise A Carolan; Steve Rockman; Kathryn Borg; Teagan Guarnaccia; Patrick Reading; Jennifer Mosse; Anne Kelso; Ian Barr; Karen L Laurie
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

3.  pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.

Authors:  Thomas Gerlach; Luca Hensen; Tatyana Matrosovich; Janina Bergmann; Michael Winkler; Christin Peteranderl; Hans-Dieter Klenk; Friedemann Weber; Susanne Herold; Stefan Pöhlmann; Mikhail Matrosovich
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

4.  Avian influenza risk perception and preventive behavior among traditional market workers and shoppers in Taiwan: practical implications for prevention.

Authors:  Pei-Chun Kuo; Jiun-Hau Huang; Ming-Der Liu
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

5.  Antiviral activity of phenanthrenes from the medicinal plant Bletilla striata against influenza A virus.

Authors:  Ya Shi; Bing Zhang; Yiyu Lu; Chaodong Qian; Yan Feng; Liwei Fang; Zhishan Ding; Dongqing Cheng
Journal:  BMC Complement Altern Med       Date:  2017-05-22       Impact factor: 3.659

Review 6.  Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates.

Authors:  Henu Kumar Verma; Batoul Farran; Lakkakula V K S Bhaskar
Journal:  Antib Ther       Date:  2020-05-27

7.  Dereplication by High-Performance Liquid Chromatography (HPLC) with Quadrupole-Time-of-Flight Mass Spectroscopy (qTOF-MS) and Antiviral Activities of Phlorotannins from Ecklonia cava.

Authors:  Hyo Moon Cho; Thi Phuong Doan; Thi Kim Quy Ha; Hyun Woo Kim; Ba Wool Lee; Ha Thanh Tung Pham; Tae Oh Cho; Won Keun Oh
Journal:  Mar Drugs       Date:  2019-03-04       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.